Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Apr 2022 for Aspira Women's Health Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
James T. Lafrance: trading record in brief
James T. Lafrance, listed as chief executive, appears in our data through filings on Aspira Women's Health Inc. shares, published by SEC (Form 4). Over a trading history stretching from 6 May 2021 to 31 March 2022, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 4 April 2022 came the latest disclosure, a share grant in Aspira Women's Health Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James T. Lafrance
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
72,937 shares0Common StockSEC:0001162956-22-000001:0
330 shares0Common StockSEC:0001162956-21-000003:0
423 shares0Common StockSEC:0001162956-21-000002:0
3 of 3 declarations
